{"transactions":[{"id":824216,"issuer":{"id":7868,"kind":"organization","name":"Volato Group, Inc.","symbol":"SOAR"},"owners":[{"id":55055,"kind":"person","name":"Heinen Mark","position":1,"cik":"0001888531","reported_name":"Heinen Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-31T12:07:08.000Z","date":"2026-03-27","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0.26,"value":2600.0,"ownership":{"direct":true},"balance_after":60919,"source":{"system":"sec-edgar","filing":"0001628280-26-022229","document":"wk-form4_1774958825.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853070/000162828026022229/wk-form4_1774958825.xml","form_type":"4"}},{"id":1153858,"issuer":{"id":7868,"kind":"organization","name":"Volato Group, Inc.","symbol":"SOAR"},"owners":[{"id":55055,"kind":"person","name":"Heinen Mark","position":1,"cik":"0001888531","reported_name":"Heinen Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-09T21:10:21.000Z","date":"2025-05-07","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares represent a restricted stock award (RSA) granted under the 2023 Stock Incentive Plan.  The RSA vested immediately.  The award of the RSA is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16b-3(d)(1) promulgated thereunder."}],"balance_after":192963,"source":{"system":"sec-edgar","filing":"0001628280-25-024366","document":"wk-form4_1746825013.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853070/000162828025024366/wk-form4_1746825013.xml","form_type":"4"}},{"id":1483681,"issuer":{"id":7868,"kind":"organization","name":"Volato Group, Inc.","symbol":"SOAR"},"owners":[{"id":55055,"kind":"person","name":"Heinen Mark","position":1,"cik":"0001888531","reported_name":"Heinen Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2024-06-11T22:48:02.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":47840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Performance-Based RSU represents a contingent right to receive one share of SOAR common stock. The performance rights vest upon SOAR's common stock achieving a specified price per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Performance-Based RSU represents a contingent right to receive one share of SOAR common stock. The performance rights vest upon SOAR's common stock achieving a specified price per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Performance-Based RSU represents a contingent right to receive one share of SOAR common stock. The performance rights vest upon SOAR's common stock achieving a specified price per share."}],"balance_after":47840,"derivative":{"underlying":"Common Stock","underlying_shares":47840},"source":{"system":"sec-edgar","filing":"0001628280-24-027731","document":"wk-form4_1718146075.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1853070/000162828024027731/wk-form4_1718146075.xml","form_type":"4"}},{"id":1483680,"issuer":{"id":7868,"kind":"organization","name":"Volato Group, Inc.","symbol":"SOAR"},"owners":[{"id":55055,"kind":"person","name":"Heinen Mark","position":1,"cik":"0001888531","reported_name":"Heinen Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-06-11T22:48:02.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":139463,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares represent Restricted Stock Units (\"RSUs\") granted on June 7, 2024. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 123,038 RSU's shall vest 25% of the shares subject to 12 months of continuous employment on the vesting commencement date and 1/48th shall vest subject to continuous employment thereafter. 16,425 RSU's shall vest 25% of the shares subject to 12 months of continuous employment the vesting commencement date and 1/48th shall vest subject to continuous employment thereafter."}],"balance_after":147963,"source":{"system":"sec-edgar","filing":"0001628280-24-027731","document":"wk-form4_1718146075.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853070/000162828024027731/wk-form4_1718146075.xml","form_type":"4"}},{"id":1485136,"issuer":{"id":7868,"kind":"organization","name":"Volato Group, Inc.","symbol":"SOAR"},"owners":[{"id":55055,"kind":"person","name":"Heinen Mark","position":1,"cik":"0001888531","reported_name":"Heinen Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-06-10T22:15:33.000Z","date":"2024-06-06","kind":"purchase","planned":false,"acquired":true,"shares":8500,"price":0.8,"value":6800.0,"ownership":{"direct":true},"balance_after":8500,"source":{"system":"sec-edgar","filing":"0001628280-24-027587","document":"wk-form4_1718057726.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853070/000162828024027587/wk-form4_1718057726.xml","form_type":"4"}},{"id":1915405,"issuer":{"id":94385,"kind":"organization","name":"Better Therapeutics, Inc.","symbol":"BTTX"},"owners":[{"id":55055,"kind":"person","name":"Heinen Mark","position":1,"cik":"0001888531","reported_name":"Heinen Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-21T18:14:15.000Z","date":"2023-03-01","kind":"grant","planned":false,"acquired":true,"shares":28550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests as to 1/4 of the shares subject to the stock option on March 1, 2024 and the remaining shares vest in 36 equal monthly installments thereafter, provided the Reporting Person continues to have a service relationship with Issuer on each vesting date. The stock option was granted on March 1, 2023."}],"balance_after":28550,"derivative":{"exercise_price":1.14,"expiration_date":"2033-02-28","underlying":"Common Stock","underlying_shares":28550},"source":{"system":"sec-edgar","filing":"0000950170-23-013898","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1832415/000095017023013898/ownership.xml","form_type":"4"}},{"id":1915404,"issuer":{"id":94385,"kind":"organization","name":"Better Therapeutics, Inc.","symbol":"BTTX"},"owners":[{"id":55055,"kind":"person","name":"Heinen Mark","position":1,"cik":"0001888531","reported_name":"Heinen Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-04-21T18:14:15.000Z","date":"2023-04-05","kind":"grant","planned":false,"acquired":true,"shares":54000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares represent restricted stock units (each, an \"RSU\") granted on April 5, 2023, which vest as to 1/2 of the shares on March 24, 2024 and the remaining shares vest on March 24, 2025, provided the Reporting Person continues to have a service relationship with Issuer on each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":139723,"source":{"system":"sec-edgar","filing":"0000950170-23-013898","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1832415/000095017023013898/ownership.xml","form_type":"4"}},{"id":2097682,"issuer":{"id":94385,"kind":"organization","name":"Better Therapeutics, Inc.","symbol":"BTTX"},"owners":[{"id":55055,"kind":"person","name":"Heinen Mark","position":1,"cik":"0001888531","reported_name":"Heinen Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-12-02T16:15:52.000Z","date":"2022-11-30","kind":"grant","acquired":true,"shares":15723,"price":1.241,"value":19512.243,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Better Therapeutics, Inc. 2021 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":85723,"source":{"system":"sec-edgar","filing":"0000899243-22-037417","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1832415/000089924322037417/doc4.xml","form_type":"4"}},{"id":2159058,"issuer":{"id":94385,"kind":"organization","name":"Better Therapeutics, Inc.","symbol":"BTTX"},"owners":[{"id":55055,"kind":"person","name":"Heinen Mark","position":1,"cik":"0001888531","reported_name":"Heinen Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-09-14T16:37:42.000Z","date":"2022-09-13","kind":"purchase","acquired":true,"shares":26132,"price":1.94,"value":50696.08,"ownership":{"direct":true},"balance_after":70000,"source":{"system":"sec-edgar","filing":"0000899243-22-031045","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1832415/000089924322031045/doc4.xml","form_type":"4"}},{"id":2159057,"issuer":{"id":94385,"kind":"organization","name":"Better Therapeutics, Inc.","symbol":"BTTX"},"owners":[{"id":55055,"kind":"person","name":"Heinen Mark","position":1,"cik":"0001888531","reported_name":"Heinen Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-09-14T16:37:42.000Z","date":"2022-09-12","kind":"purchase","acquired":true,"shares":23868,"price":1.94,"value":46303.92,"ownership":{"direct":true},"balance_after":43868,"source":{"system":"sec-edgar","filing":"0000899243-22-031045","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1832415/000089924322031045/doc4.xml","form_type":"4"}},{"id":2219928,"issuer":{"id":94385,"kind":"organization","name":"Better Therapeutics, Inc.","symbol":"BTTX"},"owners":[{"id":55055,"kind":"person","name":"Heinen Mark","position":1,"cik":"0001888531","reported_name":"Heinen Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-06-28T16:24:56.000Z","date":"2022-06-24","kind":"purchase","acquired":true,"shares":2280.605,"price":1.7539,"value":3999.9531095,"ownership":{"direct":false,"nature":"By daughter"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.7539 to $1.7576, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":2280.605,"source":{"system":"sec-edgar","filing":"0000899243-22-024391","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1832415/000089924322024391/doc4.xml","form_type":"4"}},{"id":2235224,"issuer":{"id":94385,"kind":"organization","name":"Better Therapeutics, Inc.","symbol":"BTTX"},"owners":[{"id":55055,"kind":"person","name":"Heinen Mark","position":1,"cik":"0001888531","reported_name":"Heinen Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-06-10T18:23:06.000Z","date":"2022-06-10","kind":"purchase","acquired":true,"shares":5000,"price":1.56,"value":7800.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0000899243-22-021998","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1832415/000089924322021998/doc4.xml","form_type":"4"}},{"id":2306962,"issuer":{"id":94385,"kind":"organization","name":"Better Therapeutics, Inc.","symbol":"BTTX"},"owners":[{"id":55055,"kind":"person","name":"Heinen Mark","position":1,"cik":"0001888531","reported_name":"Heinen Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-04T16:28:25.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":32800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 1/4 of the shares subject to the stock option on April 1, 2023 and the remaining shares vest in 36 equal monthly installments thereafter, provided the Reporting Person continues to have a service relationship with Issuer on each vesting date. The stock option was granted on April 1, 2022."}],"balance_after":32800,"derivative":{"exercise_price":1.97,"expiration_date":"2032-03-31","underlying":"Common Stock","underlying_shares":32800},"source":{"system":"sec-edgar","filing":"0000899243-22-013344","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1832415/000089924322013344/doc4.xml","form_type":"4"}},{"id":2306961,"issuer":{"id":94385,"kind":"organization","name":"Better Therapeutics, Inc.","symbol":"BTTX"},"owners":[{"id":55055,"kind":"person","name":"Heinen Mark","position":1,"cik":"0001888531","reported_name":"Heinen Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-04-04T16:28:25.000Z","date":"2022-03-31","kind":"purchase","acquired":true,"shares":5000,"price":1.98,"value":9900.0,"ownership":{"direct":true},"balance_after":15000,"source":{"system":"sec-edgar","filing":"0000899243-22-013344","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1832415/000089924322013344/doc4.xml","form_type":"4"}},{"id":2471088,"issuer":{"id":94385,"kind":"organization","name":"Better Therapeutics, Inc.","symbol":"BTTX"},"owners":[{"id":55055,"kind":"person","name":"Heinen Mark","position":1,"cik":"0001888531","reported_name":"Heinen Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-12-15T16:53:32.000Z","date":"2021-12-15","kind":"purchase","acquired":true,"shares":2333,"price":4.695,"value":10953.435,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0000899243-21-048374","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1832415/000089924321048374/doc4.xml","form_type":"4"}},{"id":2471087,"issuer":{"id":94385,"kind":"organization","name":"Better Therapeutics, Inc.","symbol":"BTTX"},"owners":[{"id":55055,"kind":"person","name":"Heinen Mark","position":1,"cik":"0001888531","reported_name":"Heinen Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-12-15T16:53:32.000Z","date":"2021-12-14","kind":"purchase","acquired":true,"shares":500,"price":5.4424,"value":2721.2,"ownership":{"direct":true},"balance_after":7667,"source":{"system":"sec-edgar","filing":"0000899243-21-048374","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1832415/000089924321048374/doc4.xml","form_type":"4"}},{"id":2471086,"issuer":{"id":94385,"kind":"organization","name":"Better Therapeutics, Inc.","symbol":"BTTX"},"owners":[{"id":55055,"kind":"person","name":"Heinen Mark","position":1,"cik":"0001888531","reported_name":"Heinen Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-12-15T16:53:32.000Z","date":"2021-12-13","kind":"purchase","acquired":true,"shares":500,"price":5.45,"value":2725.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects the correction of an immaterial error in Column 5 reported in the Reporting Person's Form 4 filed on November 1, 2021."}],"balance_after":7167,"source":{"system":"sec-edgar","filing":"0000899243-21-048374","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1832415/000089924321048374/doc4.xml","form_type":"4"}},{"id":2530250,"issuer":{"id":94385,"kind":"organization","name":"Better Therapeutics, Inc.","symbol":"BTTX"},"owners":[{"id":55055,"kind":"person","name":"Heinen Mark","position":1,"cik":"0001888531","reported_name":"Heinen Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-01T20:47:52.000Z","date":"2021-10-28","kind":"grant","acquired":true,"shares":51920,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Following the Issuer's filing of Form S-8 to register the shares subject to the stock option, the stock option vests as to 1/4 of the shares subject to the stock option on May 10, 2022 and the remaining shares vest in 36 equal monthly installments thereafter, provided the Reporting Person continues to have a service relationship with Issuer on each vesting date.  The stock option was granted on October 28, 2021."}],"balance_after":51920,"derivative":{"exercise_price":10.97,"expiration_date":"2031-10-27","underlying":"Common Stock","underlying_shares":51920},"source":{"system":"sec-edgar","filing":"0000899243-21-042247","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1832415/000089924321042247/doc4.xml","form_type":"4"}},{"id":2530249,"issuer":{"id":94385,"kind":"organization","name":"Better Therapeutics, Inc.","symbol":"BTTX"},"owners":[{"id":55055,"kind":"person","name":"Heinen Mark","position":1,"cik":"0001888531","reported_name":"Heinen Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-11-01T20:47:52.000Z","date":"2021-10-28","kind":"grant","acquired":true,"shares":6667,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated April 6, 2021, as amended (the \"Merger Agreement\"), by and among Mountain Crest Acquisition Corp. II (\"Issuer\"), MCAD Merger Sub Inc. (\"Merger Sub\") and Better Therapeutics, Inc. (\"BTX\"), on October 28, 2021, Merger Sub merged with and into BTX, with BTX surviving the merger as a wholly-owned subsidiary of Issuer (such merger and the other transactions contemplated by the Merger Agreement, the \"Business Combination\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"At the effective time of the Business Combination, each share of BTX common stock (including shares of BTX common stock resulting from the conversion of BTX preferred stock and BTX Simple Agreements for Future Equity) was converted into a right to receive the number of shares of Issuer common stock equal to the product of the number of shares of BTX common stock and 0.9475, with fractional shares rounded to the nearest whole share. Issuer subsequently changed its name to Better Therapeutics, Inc."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated April 6, 2021, as amended (the \"Merger Agreement\"), by and among Mountain Crest Acquisition Corp. II (\"Issuer\"), MCAD Merger Sub Inc. (\"Merger Sub\") and Better Therapeutics, Inc. (\"BTX\"), on October 28, 2021, Merger Sub merged with and into BTX, with BTX surviving the merger as a wholly-owned subsidiary of Issuer (such merger and the other transactions contemplated by the Merger Agreement, the \"Business Combination\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the effective time of the Business Combination, each share of BTX common stock (including shares of BTX common stock resulting from the conversion of BTX preferred stock and BTX Simple Agreements for Future Equity) was converted into a right to receive the number of shares of Issuer common stock equal to the product of the number of shares of BTX common stock and 0.9475, with fractional shares rounded to the nearest whole share. Issuer subsequently changed its name to Better Therapeutics, Inc."}],"balance_after":33333,"source":{"system":"sec-edgar","filing":"0000899243-21-042247","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1832415/000089924321042247/doc4.xml","form_type":"4"}}]}